Meta Biomed Co., Ltd. (KOSDAQ:059210)
South Korea · Delayed Price · Currency is KRW 3,975.00
+90.00 (2.32%)
At close: Aug 6, 2026
Meta Biomed Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 99,671 | 102,951 | 94,036 | 83,101 | 68,942 | 58,780 |
Revenue Growth | 0.44% | 9.48% | 13.16% | 20.54% | 17.29% | 30.63% |
Gross Profit Gross Profit Growth | 53,370 | 53,593 | 47,361 | 37,990 | 29,196 | 25,003 |
Operating Income Operating Income Growth | 20,431 | 21,194 | 17,222 | 10,602 | 5,365 | 5,261 |
Net Income Net Income Growth | 9,781 | 10,988 | 22,402 | 10,080 | 2,628 | 9,522 |
Earnings Per Share EPS Growth | 358.29 | 437.65 | 655.73 | 440.75 | 114.82 | 415.77 |
EPS Growth | -45.22% | -33.26% | 48.78% | 283.85% | -72.38% | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Other Other Growth | 9,583 | 8,950 | 5,604 | 7,009 | 6,037 | 4,921 |
Suture Suture Growth | 42,535 | 44,086 | 42,505 | 32,799 | 26,642 | 21,337 |
Dental Division Dental Division Growth | 47,196 | 49,916 | 45,927 | 43,293 | 36,262 | 31,461 |
Total Total Growth | 99,671 | 102,951 | 94,036 | 83,101 | 68,942 | 58,780 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 37,749 | 37,863 | 54,298 | 16,810 | 19,141 | 15,916 |
Total Debt Total Debt Growth | 44,235 | 42,720 | 56,123 | 44,448 | 44,072 | 34,478 |
Net Cash (Debt) Net Cash Growth | -6,487 | -4,857 | -1,824 | -27,638 | -24,931 | -18,562 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -247.74 | -193.45 | -67.29 | -1208.43 | -1089.37 | -810.54 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 17,064 | 19,833 | 22,633 | 10,217 | 9,159 | 11,136 |
Capital Expenditures CapEx Growth | -18,468 | -20,304 | -10,914 | -11,489 | -15,395 | -2,067 |
Free Cash Flow Free Cash Flow Growth | -1,405 | -471.17 | 11,719 | -1,271 | -6,236 | 9,069 |
Free Cash Flow Growth | - | - | - | - | - | 244.28% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 53.55% | 52.06% | 50.36% | 45.72% | 42.35% | 42.54% |
Operating Margin | 20.50% | 20.59% | 18.31% | 12.76% | 7.78% | 8.95% |
Pretax Margin | 11.40% | 12.23% | 24.77% | 9.39% | 4.22% | 12.90% |
Profit Margin | 9.81% | 10.67% | 23.82% | 12.13% | 3.81% | 16.20% |
FCF Margin | -1.41% | -0.46% | 12.46% | -1.53% | -9.04% | 15.43% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 105.000 | 105.000 | 30.000 | 20.000 | 20.000 | 20.000 |
Dividend Per Share Growth | 0% | 250.00% | 50.00% | 0% | 0% | 100.00% |
Dividend Yield | 2.70% | 2.14% | 0.84% | 0.48% | 0.91% | 0.73% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 11.09 | 12.24 | 3.79 | 9.89 | 20.11 | 6.95 |
Forward PE | 5.90 | 6.08 | - | - | - | - |
P/FCF Ratio | - | - | 7.24 | - | - | 7.30 |
PS Ratio | 1.08 | 1.31 | 0.90 | 1.20 | 0.77 | 1.13 |